Contact
searchSearch
HMP Global
Login

ADHD Education Center

Featured

Viloxazine MOA Study image
Quiz
Test Your Knowledge: New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/12/2026
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that...
06/12/2026
Psych Congress Network
Weight scale and tape measure
Quiz
Test Your Knowledge: Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/12/2026
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the...
06/12/2026
Psych Congress Network
Viloxazine MOA Study image
News
New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/11/2026
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further...
06/11/2026
Psych Congress Network
Weight scale and tape measure
News
Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/11/2026
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study...
06/11/2026
Psych Congress Network
Kids ride their bikes down a dirt path in a grassy field
Conference Coverage
d-ATS Shows Broad ADHD Efficacy in Pediatric Subgroups
06/06/2026
Brionna Mendoza
A poster presented at the 2026 Psych Congress Elevate reported that the dextroamphetamine transdermal system (d-ATS) was broadly effective for treating attention-deficit/hyperactivity disorder (ADHD) in children and adolescents.
A poster presented at the 2026 Psych Congress Elevate reported that the dextroamphetamine transdermal system (d-ATS) was broadly effective for treating attention-deficit/hyperactivity disorder (ADHD) in children and adolescents.
A poster presented at the 2026...
06/06/2026
Psych Congress Network
Girl in a classroom staring off into the distance
Quiz
Test Your Knowledge – Beyond the Stereotype: Rethinking Sex Differences in ADHD Presentation
05/12/2026
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation...
05/12/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
Quiz
Test Your Knowledge: The Link Between Ultra-Processed Foods and ADHD
05/12/2026
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the...
05/12/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
News
The Link Between Ultra-Processed Foods and ADHD
05/12/2026
Recent findings point to a possible link between ADHD and higher intake of ultra-processed foods.
Recent findings point to a possible link between ADHD and higher intake of ultra-processed foods.
Recent findings point to a...
05/12/2026
Psych Congress Network
Girl in a classroom staring off into the distance
Commentary
Beyond the Stereotype: Rethinking Sex Differences in ADHD Presentation
05/08/2026
This article explores how ADHD presents differently across sexes and why traditional diagnostic models may overlook symptoms in females.
This article explores how ADHD presents differently across sexes and why traditional diagnostic models may overlook symptoms in females.
This article explores how ADHD...
05/08/2026
Psych Congress Network
a girl playing a game on a tablet while lying on her stomach
Quiz
Test Your Knowledge—Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx...
04/23/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
Quiz
Long-Term Effects of Viloxazine ER in Treatment of Pediatric ADHD
04/23/2026
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test...
04/23/2026
Psych Congress Network

Videos

Timothy Wilens, MD
Videos
Clinical Patterns of ADHD Comorbidities Across the Lifespan
04/01/2026
Timothy Wilens, MD
Timothy Wilens, MD, explores common patterns of attention-deficit/hyperactivity disorder (ADHD) psychiatric comorbidities throughout different developmental stages.
Timothy Wilens, MD, explores common patterns of attention-deficit/hyperactivity disorder (ADHD) psychiatric comorbidities throughout different developmental stages.
Timothy Wilens, MD, explores...
04/01/2026
Psych Congress Network
Greg Mattingly, MD
Videos
Breaking Down Treatment Barriers for Girls and Women With ADHD
07/24/2025
Greg Mattingly, MD
In this video, Psych Congress Co-Chair Greg Mattingly, MD, dives into the factors that prevent girls and women from receiving ADHD diagnoses earlier in life.
In this video, Psych Congress Co-Chair Greg Mattingly, MD, dives into the factors that prevent girls and women from receiving ADHD diagnoses earlier in life.
In this video, Psych Congress...
07/24/2025
Psych Congress Network
Sarah Slabaugh
Videos
Assessing Shame-Based Family Dynamics When Treating Children With ADHD
06/19/2025
Sarah Slabaugh, DO
Filmed ahead of her 2025 Psych Congress Elevate session, Sarah Slabaugh, DO, offers practical insights on identifying dysfunctional family patterns that may impact the presentation of ADHD symptoms in child and adolescent patients.
Filmed ahead of her 2025 Psych Congress Elevate session, Sarah Slabaugh, DO, offers practical insights on identifying dysfunctional family patterns that may impact the presentation of ADHD symptoms in child and adolescent patients.
Filmed ahead of her 2025 Psych...
06/19/2025
Psych Congress Network
Timothy Wilens, MD
Videos
Managing Life Transitions in ADHD: Why Early Preparation is Critical
09/18/2024
Timothy Wilens, MD
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides...
09/18/2024
Psych Congress Network
Julie Carbray, PhD, APRN
Videos
Screening Tools for Adult and Pediatric ADHD
08/22/2024
Julie A. Carbray, PhD, APRN
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder.  
Julie Carbray, PhD, FPMHNP-BC,...
08/22/2024
Psych Congress Network
Drs Mattingly, Price, Amann Part 3
Videos
Navigating ADHD Care Forward: The Future of ADHD
01/15/2024
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann focus on the evolving future of the ADHD landscape and address current unmet needs in ADHD treatment for both adult and...
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann focus on the evolving future of the ADHD landscape and address current unmet needs in ADHD treatment for both adult and...
In this roundtable discussion...
01/15/2024
Psych Congress Network
Drs Mattingly, Price, Amann Part 1
Videos
ADHD Unmasked: Current ADHD Treatment Landscape
01/15/2024
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann delve into the evolving landscape of ADHD treatment. The panelists discuss current treatment options, including...
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann delve into the evolving landscape of ADHD treatment. The panelists discuss current treatment options, including...
In this roundtable discussion...
01/15/2024
Psych Congress Network
Drs Mattingly, Price, Amann Part 2
Videos
Real-World Data Deep Dive: Viloxazine ER Compared With Atomoxetine for ADHD Study
12/12/2023
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann explore key findings from the real-world study comparing viloxazine ER with atomoxetine for ADHD treatment in adult and...
In this roundtable discussion featuring a panel of experts, Dr Gregory Mattingly, Dr Richard Price, and Dr Birgit Amann explore key findings from the real-world study comparing viloxazine ER with atomoxetine for ADHD treatment in adult and...
In this roundtable discussion...
12/12/2023
Psych Congress Network
Greg Mattingly, MD, and Elizabeth Judd, NP, MHS
Videos
How to Incorporate Non-Stimulants Into ADHD Treatment Plans
06/05/2023
Greg Mattingly, MD, and Elizabeth Judd, NP, MHS, discuss how clinicians can incorporate non-stimulant medication into their ADHD treatment plans.
Greg Mattingly, MD, and Elizabeth Judd, NP, MHS, discuss how clinicians can incorporate non-stimulant medication into their ADHD treatment plans.
Greg Mattingly, MD, and...
06/05/2023
Psych Congress Network
Manpreet Singh
Videos
Pediatric ADHD: Proper Diagnosis, Stimulant Therapy
12/16/2021
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet Singh, MD, MS,...
12/16/2021
Psych Congress Network
Jain, Mattingly, and Raison
Rapid Reaction
Rapid Reactions: Psych Congress Faculty Respond to HHS Deprescribing Initiative
05/12/2026
Rakesh Jain, MD, MPH, RD; Greg Mattingly, MD; Charles L. Raison, MD
Psych Congress faculty members share their expert perspectives on the HHS deprescribing action plan and Dear Colleague letter.
Psych Congress faculty members share their expert perspectives on the HHS deprescribing action plan and Dear Colleague letter.
Psych Congress faculty members...
05/12/2026
Psych Congress Network
Craig Chepke, MD, DFAPA
Videos
Treating Beyond AIMS Scores: Tracking Functional Outcomes in Tardive Dyskinesia
05/12/2026
Craig Chepke, MD, DFAPA
In this video, Craig Chepke, MD, DFAPA, Chief Medical Officer, Psych Congress, discusses the pitfalls of evaluating tardive dyskinesia (TD) treatment progress by an Abnormal Involuntary Movement Scale (AIMS) score alone.
In this video, Craig Chepke, MD, DFAPA, Chief Medical Officer, Psych Congress, discusses the pitfalls of evaluating tardive dyskinesia (TD) treatment progress by an Abnormal Involuntary Movement Scale (AIMS) score alone.
In this video, Craig Chepke, MD,...
05/12/2026
Psych Congress Network
Craig Chepke, MD, DFAPA
Videos
Treating Beyond AIMS Scores: Tracking Functional Outcomes in Tardive Dyskinesia
05/12/2026
Craig Chepke, MD, DFAPA
In this video, Craig Chepke, MD, DFAPA, Chief Medical Officer, Psych Congress, discusses the pitfalls of evaluating tardive dyskinesia (TD) treatment progress by an Abnormal Involuntary Movement Scale (AIMS) score alone.
In this video, Craig Chepke, MD, DFAPA, Chief Medical Officer, Psych Congress, discusses the pitfalls of evaluating tardive dyskinesia (TD) treatment progress by an Abnormal Involuntary Movement Scale (AIMS) score alone.
In this video, Craig Chepke, MD,...
05/12/2026
Psych Congress Network
Brooke Kempf, PMHNP-BC
Videos
Navigating Anxiety, Pain, and Mixed Features in Depressive Disorders
04/16/2026
Brooke Kempf, MSN, PMHNP-BC
Psych Congress Steering Committee member Brooke Kempf, PMHNP-BC, offers clinicians a practical framework for differentiating overlapping symptoms, anxious distress, and mixed features in MDD.
Psych Congress Steering Committee member Brooke Kempf, PMHNP-BC, offers clinicians a practical framework for differentiating overlapping symptoms, anxious distress, and mixed features in MDD.
Psych Congress Steering...
04/16/2026
Psych Congress Network
Philip Gehrman, PhD, CBSM, FAASM
Videos
Targeting Sleep to Improve Mental Health Outcomes
04/08/2026
Philip Gehrman, PhD
Psych Congress Steering Committee Partner Philip Gehrman, PhD, CBSM, FAASM, discusses how targeting sleep may improve outcomes for patients with co-occurring sleep and psychiatric disorders.
Psych Congress Steering Committee Partner Philip Gehrman, PhD, CBSM, FAASM, discusses how targeting sleep may improve outcomes for patients with co-occurring sleep and psychiatric disorders.
Psych Congress Steering...
04/08/2026
Psych Congress Network
Timothy Wilens, MD
Videos
Clinical Patterns of ADHD Comorbidities Across the Lifespan
04/01/2026
Timothy Wilens, MD
Timothy Wilens, MD, explores common patterns of attention-deficit/hyperactivity disorder (ADHD) psychiatric comorbidities throughout different developmental stages.
Timothy Wilens, MD, explores common patterns of attention-deficit/hyperactivity disorder (ADHD) psychiatric comorbidities throughout different developmental stages.
Timothy Wilens, MD, explores...
04/01/2026
Psych Congress Network
Brittany Albright MD, MPH
Videos
Taking a Patient-Centered Approach to Deprescribing in Psychiatry
03/13/2026
Brittany Albright, MD, MPH
In this insightful discussion, Brittany Albright, MD, MPH, Co-Chair, Psych Congress Elevate, offers a comprehensive overview of the role that deprescribing plays in effective psychiatric care.
In this insightful discussion, Brittany Albright, MD, MPH, Co-Chair, Psych Congress Elevate, offers a comprehensive overview of the role that deprescribing plays in effective psychiatric care.
In this insightful discussion,...
03/13/2026
Psych Congress Network
Chelsie Monroe, APN, PMHNP-BC
Videos
Is It Fatigue or Sleepiness? Identifying Narcolepsy in Practice
03/09/2026
Chelsie Monroe, PMHNP-BC, APN
Chelsie Monroe, APN, PMHNP-BC, discusses practical screening strategies, including the use of the Epworth Sleepiness Scale, the importance of collaboration with sleep specialists, and the clinical relevance of the orexin system.
Chelsie Monroe, APN, PMHNP-BC, discusses practical screening strategies, including the use of the Epworth Sleepiness Scale, the importance of collaboration with sleep specialists, and the clinical relevance of the orexin system.
Chelsie Monroe, APN, PMHNP-BC,...
03/09/2026
Psych Congress Network
Desiree Matthews, PMHNP-BC
Videos
Practical Guidance for Ethical AI Use in Psychiatry
03/06/2026
Desiree Matthews, PHMNP-BC
In this video, Desiree Matthews, PMHNP-BC, Steering Committee, Psych Congress, offers several practical considerations for mental health care providers contemplating the use of AI in psychiatric practice.
In this video, Desiree Matthews, PMHNP-BC, Steering Committee, Psych Congress, offers several practical considerations for mental health care providers contemplating the use of AI in psychiatric practice.
In this video, Desiree Matthews,...
03/06/2026
Psych Congress Network
Saundra Jain, MA, PsyD, LPC
Videos
Integrating Digital Therapeutics Into GAD Care
02/20/2026
Saundra Jain, MA, PsyD, LPC
Saundra Jain, MA, PsyD, LPC, discusses how clinicians can leverage digital therapeutics for the treatment of generalized anxiety disorder (GAD).
Saundra Jain, MA, PsyD, LPC, discusses how clinicians can leverage digital therapeutics for the treatment of generalized anxiety disorder (GAD).
Saundra Jain, MA, PsyD, LPC,...
02/20/2026
Psych Congress Network

News Articles

Viloxazine MOA Study image
News
New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/11/2026
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further...
06/11/2026
Psych Congress Network
Weight scale and tape measure
News
Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/11/2026
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study...
06/11/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
News
The Link Between Ultra-Processed Foods and ADHD
05/12/2026
Recent findings point to a possible link between ADHD and higher intake of ultra-processed foods.
Recent findings point to a possible link between ADHD and higher intake of ultra-processed foods.
Recent findings point to a...
05/12/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
News
Open-Label Extension Trial Supports Long-Term Use of Viloxazine ER in Children and Adolescents
04/13/2026
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension trial found viloxazine ER to be safe and effective for the long-term treatment of pediatric ADHD.
A phase 3 open-label extension...
04/13/2026
Psych Congress Network
A teddy bear against a blue background wearing a mask and stethoscope.
News

ADHD Incidence Trends Accelerated After DSM-5 Changes and COVID-19 Disruptions
04/10/2026
Brionna Mendoza
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity disorder (ADHD) diagnosis rates in people younger than 30 years in British Columbia, Canada, rose steadily from 2003 to 2023 and appeared to accelerate after both DSM-5 implementation and the COVID-19 pandemic.
Attention-deficit/hyperactivity...
04/10/2026
Psych Congress Network
News
Co-occurring ADHD Associated With Poorer Health Outcomes in Adults With Autism on Medicaid
02/02/2026
Grace Taylor, MS, MA
A large US Medicaid study finds that co-occurring attention-deficit/hyperactivity disorder (ADHD) is common among adults with autism and is linked to higher rates of substance use, cardiovascular conditions, and injury, while ADHD medication...
A large US Medicaid study finds that co-occurring attention-deficit/hyperactivity disorder (ADHD) is common among adults with autism and is linked to higher rates of substance use, cardiovascular conditions, and injury, while ADHD medication...
A large US Medicaid study finds...
02/02/2026
First Report Managed Care
A young boy sits at a desk in a classroom
News
Higher Screen Time Tied to ADHD Symptoms, Altered Brain Structure in Children
12/03/2025
Brionna Mendoza
Higher digital screen time in preadolescent children is associated with worsening attention-deficit/hyperactivity disorder (ADHD) symptoms and measurable alterations in brain structure.
Higher digital screen time in preadolescent children is associated with worsening attention-deficit/hyperactivity disorder (ADHD) symptoms and measurable alterations in brain structure.
Higher digital screen time in...
12/03/2025
Psych Congress Network
stethoscope, pills, and a brain
News
Stimulant Treatment for ADHD Associated With Psychosis and BD
09/25/2025
Maria Mantas
Stimulant use for the treatment of attention-deficit/hyperactivity disorder (ADHD) was associated with higher occurrence of psychotic symptoms, psychotic disorders, and bipolar disorder (BD), according to a systematic review.
Stimulant use for the treatment of attention-deficit/hyperactivity disorder (ADHD) was associated with higher occurrence of psychotic symptoms, psychotic disorders, and bipolar disorder (BD), according to a systematic review.
Stimulant use for the treatment...
09/25/2025
Psych Congress Network
An orange prescription container with generic pills spilling out in front of it
News
Early ADHD Drug Treatment Linked With Reduced Risk of Suicide, Substance Misuse, and Other Adverse Outcomes
08/27/2025
Jolynn Tumolo
Patients with attention-deficit/hyperactivity disorder (ADHD) who began drug treatment within 3 months of diagnosis had significantly reduced rates of suicidal behaviors, substance misuse, traffic accidents, and criminality.
Patients with attention-deficit/hyperactivity disorder (ADHD) who began drug treatment within 3 months of diagnosis had significantly reduced rates of suicidal behaviors, substance misuse, traffic accidents, and criminality.
Patients with...
08/27/2025
Psych Congress Network
plastic red heart with a stethoscope wrapped around it
News
Assessing the Cardiovascular Effects of ADHD Medications
06/09/2025
A recent systematic review and network meta-analysis assessed the cardiovascular effects of ADHD medications across children, adolescents, and adults with ADHD.
A recent systematic review and network meta-analysis assessed the cardiovascular effects of ADHD medications across children, adolescents, and adults with ADHD.
A recent systematic review and...
06/09/2025
Psych Congress Network
a young woman lies awake in bed
News
Adolescent Insomnia and Daytime Sleepiness Linked to Depression Risk
06/25/2026
Maria Mantas
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression. 
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression. 
A 3-year longitudinal study...
06/25/2026
Psych Congress Network
A man with depression holds his head in his hands
Research Summary
Navacaprant Fails Late-Stage MDD Trials
06/22/2026
Brionna Mendoza
Navacaprant, a kappa opioid receptor antagonist for major depressive disorder treatment, failed to show statistically significant efficacy in two phase 3 trials.
Navacaprant, a kappa opioid receptor antagonist for major depressive disorder treatment, failed to show statistically significant efficacy in two phase 3 trials.
Navacaprant, a kappa opioid...
06/22/2026
Psych Congress Network
a man surrounded by alcohol and other substances on a table
News
Reduced Stimulant Use Outcomes May Reveal Treatment Effects Missed by Abstinence Measures
06/18/2026
Maria Mantas
Evaluating reduced stimulant use rather than complete abstinence outcomes in patients with stimulant use disorder could provide additional insight into treatment efficacy.
Evaluating reduced stimulant use rather than complete abstinence outcomes in patients with stimulant use disorder could provide additional insight into treatment efficacy.
Evaluating reduced stimulant use...
06/18/2026
Psych Congress Network
Viloxazine MOA Study image
News
New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/11/2026
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further...
06/11/2026
Psych Congress Network
Weight scale and tape measure
News
Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/11/2026
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study...
06/11/2026
Psych Congress Network
a woman scrolls on her phone while laying in bed
News
US Study Finds No Link Between AI Use and Depression
05/28/2026
Maria Mantas
A recent target trial emulation found no evidence of a causal relationship between frequent AI use and increased depressive symptoms among adults.
A recent target trial emulation found no evidence of a causal relationship between frequent AI use and increased depressive symptoms among adults.
A recent target trial emulation...
05/28/2026
Psych Congress Network
A clinician in the lab pulls a psilocybin mushroom from a bag using tweezers major depressive disorder mdd treatment
News
Single-Dose Psilocybin Rapidly Improves MDD Symptoms, RCT Finds
05/19/2026
Brionna Mendoza
A single dose of psilocybin was associated with a significant reduction in depressive symptoms within 2 days of administration in patients with major depressive disorder (MDD), according to randomized control trial results.
A single dose of psilocybin was associated with a significant reduction in depressive symptoms within 2 days of administration in patients with major depressive disorder (MDD), according to randomized control trial results.
A single dose of psilocybin was...
05/19/2026
Psych Congress Network
injection for schizophrenia treatment
News
Once-Monthly Aripiprazole Demonstrates Favorable Benefit–Risk Profile in Schizophrenia Treatment
05/14/2026
Maria Mantas
Once-monthly aripiprazole 400 mg (AOM 400) demonstrated a favorable risk-benefit profile as an acute and long-term maintenance treatment in patients with schizophrenia.
Once-monthly aripiprazole 400 mg (AOM 400) demonstrated a favorable risk-benefit profile as an acute and long-term maintenance treatment in patients with schizophrenia.
Once-monthly aripiprazole 400 mg...
05/14/2026
Psych Congress Network
A man with depression holds his head in his hands
News
Lumateperone Tops Efficacy in Adjunctive Treatment for MDD, Review Finds
05/12/2026
Brionna Mendoza
A new systematic review and network meta-analysis published in JAMA Psychiatry evaluated the comparative efficacy and acceptability of the 5 FDA-approved atypical antipsychotics used as adjunctive therapy for major depressive disorder (MDD).
A new systematic review and network meta-analysis published in JAMA Psychiatry evaluated the comparative efficacy and acceptability of the 5 FDA-approved atypical antipsychotics used as adjunctive therapy for major depressive disorder (MDD).
A new systematic review and...
05/12/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
News
The Link Between Ultra-Processed Foods and ADHD
05/12/2026
Recent findings point to a possible link between ADHD and higher intake of ultra-processed foods.
Recent findings point to a possible link between ADHD and higher intake of ultra-processed foods.
Recent findings point to a...
05/12/2026
Psych Congress Network

Podcasts

Dr Rakesh Jain
Podcasts
Targeting Hyperactivity and Impulsivity in Adolescents: A Look at Viloxazine ER
04/17/2025
Rakesh Jain, MD, MPH, RD
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he...
04/17/2025
Psych Congress Network
Dr Greg Mattingly
Podcasts
Viloxazine ER: A New Era in ADHD Treatment?
04/17/2025
Greg Mattingly, MD
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he...
04/17/2025
Psych Congress Network
Greg Mattingly, MD
Podcasts
Managing Pediatric ADHD and Stress During the Holidays
12/03/2021
Greg Mattingly, MD
Greg Mattingly, MD, shares tips and advice on managing pediatric ADHD and stress through the holiday season.
Greg Mattingly, MD, shares tips and advice on managing pediatric ADHD and stress through the holiday season.
Greg Mattingly, MD, shares tips...
12/03/2021
Psych Congress Network
Rakesh Jain and Craig Chepke
Podcasts
Psych Congress Family & Friends Podcast, Episode 8: Beyond the Headlines: The Good, The Bad, and The Ugly of SSRIs
10/09/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA; Ragy R. Girgis, MD, MS
In this episode, Drs Rakesh Jain and Craig Chepke are joined by Dr Ragy Girgis of Columbia University to explore the small but important nuances around antidepressants, black box warnings, and violence risk in untreated psychosis.
In this episode, Drs Rakesh Jain and Craig Chepke are joined by Dr Ragy Girgis of Columbia University to explore the small but important nuances around antidepressants, black box warnings, and violence risk in untreated psychosis.
In this episode, Drs Rakesh Jain...
10/09/2025
Psych Congress Network
Craig Chepke and Rakesh Jain
Podcasts
Psych Congress Family & Friends Podcast, Episode 7: Sleep is the Foundation of Mental Health
09/12/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Sleep–wake disorders are clinically significant and too often overlooked in psychiatric practice. Drs. Rakesh Jain and Craig Chepke share practical strategies for recognizing and treating insomnia, hypersomnia, and obstructive sleep apnea.
Sleep–wake disorders are clinically significant and too often overlooked in psychiatric practice. Drs. Rakesh Jain and Craig Chepke share practical strategies for recognizing and treating insomnia, hypersomnia, and obstructive sleep apnea.
Sleep–wake disorders are...
09/12/2025
Psych Congress Network
Rakesh Jain and Craig Chepke
Podcasts
Psych Congress Family & Friends Podcast, Episode 6: Psychiatry Is the Specialty That Speaks for Those Without a Voice
09/08/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Drs Rakesh Jain and Craig Chepke explore why fibromyalgia belongs in psychiatry’s wheelhouse and address the stigma patients face every day.
In this episode, Drs Rakesh Jain and Craig Chepke explore why fibromyalgia belongs in psychiatry’s wheelhouse and address the stigma patients face every day.
In this episode, Drs Rakesh Jain...
09/08/2025
Psych Congress Network
Craig Chepke and Rakesh Jain
Podcasts
Psych Congress Family & Friends Podcast, Episode 5: We’re Too Addicted to Our Own Good Ideas
08/25/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
In this episode, Drs Rakesh Jain and Craig Chepke reflect on how the words we use—and the habits we form—shape the way we practice. The pair also take a fresh look at the serotonin story, talk through new ways of understanding depression, and...
In this episode, Drs Rakesh Jain and Craig Chepke reflect on how the words we use—and the habits we form—shape the way we practice. The pair also take a fresh look at the serotonin story, talk through new ways of understanding depression, and...
In this episode, Drs Rakesh Jain...
08/25/2025
Psych Congress Network
craig chepke and rakesh jain
Podcasts
Psych Congress Family & Friends Podcast, Episode 4: Every Pill is a Choice
07/25/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Through a positive psychiatry lens, Drs Rakesh Jain and Craig Chepke reflect on recent research, the challenges of psychiatric diagnosis, and why every treatment decision should begin with a deep understanding of the person in front of us.
Through a positive psychiatry lens, Drs Rakesh Jain and Craig Chepke reflect on recent research, the challenges of psychiatric diagnosis, and why every treatment decision should begin with a deep understanding of the person in front of us.
Through a positive psychiatry...
07/25/2025
Psych Congress Network
Dr Rakesh Jain
Podcasts
Targeting Hyperactivity and Impulsivity in Adolescents: A Look at Viloxazine ER
04/17/2025
Rakesh Jain, MD, MPH, RD
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he explores the role of viloxazine extended-release (ER) in targeting hyperactivity and impulsivity in adolescents with ADHD.
Join Rakesh Jain, MD, MPH, as he...
04/17/2025
Psych Congress Network
Dr Greg Mattingly
Podcasts
Viloxazine ER: A New Era in ADHD Treatment?
04/17/2025
Greg Mattingly, MD
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he discusses the evolving ADHD treatment landscape, in particular extended-release viloxazine
Join Greg Mattingly, MD, as he...
04/17/2025
Psych Congress Network
Rakesh and Craig
Podcasts
Weighing the Options: Medication, Lifestyle, and the Path to Wellness
03/26/2025
Rakesh Jain, MD, MPH, RD; Craig Chepke, MD, DFAPA
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain and Dr Craig Chepke explore medication-induced weight gain in schizophrenia treatment and how clinicians can help patients take control of their health, mind, and body.
In this episode, Dr Rakesh Jain...
03/26/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
Gut Feelings: Tackling Medication-Induced Nausea
02/05/2025
Join Dr Craig Chepke and Dr Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and Dr Rakesh Jain in this episode of the Psych Congress Family & Friends Podcast as they tackle a topic that affects so many patients receiving psychiatric treatment: nausea!
Join Dr Craig Chepke and Dr...
02/05/2025
Psych Congress Network
psych congress family and friends podcast
Podcasts
A New Beginning, and a Fond Farewell
01/06/2025
Craig Chepke, MD, DFAPA; Rakesh Jain, MD, MPH, RD
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig Chepke for a discussion of feelings surrounding the recent passing of Dr Vladimir Maletic leads to an exploration of a topic near and dear to Dr Maletic's heart—the role of norepinephrine in clinical practice.
Join Dr Rakesh Jain and Dr Craig...
01/06/2025
Psych Congress Network

Commentary

Girl in a classroom staring off into the distance
Commentary
Beyond the Stereotype: Rethinking Sex Differences in ADHD Presentation
05/08/2026
This article explores how ADHD presents differently across sexes and why traditional diagnostic models may overlook symptoms in females.
This article explores how ADHD presents differently across sexes and why traditional diagnostic models may overlook symptoms in females.
This article explores how ADHD...
05/08/2026
Psych Congress Network
a girl playing a game on a tablet while lying on her stomach
Commentary
Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
This article reviews the role of digital therapeutics (DTx) as an adjunctive treatment modality for ADHD, highlighting FDA‑cleared products alongside investigational interventions. It summarizes clinical evidence, safety, and use...
This article reviews the role of digital therapeutics (DTx) as an adjunctive treatment modality for ADHD, highlighting FDA‑cleared products alongside investigational interventions. It summarizes clinical evidence, safety, and use...
This article reviews the role of...
04/23/2026
Psych Congress Network
Stressed mother next to crib with baby
Commentary
Postpartum Distress in Women With ADHD: Risks, Recognition, and Evidence-Based Management
09/25/2025
This article explores the challenges of postpartum distress in women with ADHD, highlighting how symptoms and psychiatric comorbidities can intensify during pregnancy and the postpartum period. It reviews current evidence, treatment...
This article explores the challenges of postpartum distress in women with ADHD, highlighting how symptoms and psychiatric comorbidities can intensify during pregnancy and the postpartum period. It reviews current evidence, treatment...
This article explores the...
09/25/2025
Psych Congress Network
Rx pad in the shape of a cell phone with pills on the screen
Commentary
Telehealth Stimulant Prescribing and Substance Misuse Risk: What the Evidence Really Says
09/23/2025
This article reviews two large studies that evaluated whether telehealth prescribing of stimulants for ADHD increases substance misuse risk.
This article reviews two large studies that evaluated whether telehealth prescribing of stimulants for ADHD increases substance misuse risk.
This article reviews two large...
09/23/2025
Psych Congress Network
Hyper child jumps on couch while mom holds head in hands
Commentary
Beyond Symptoms: The Impact of Stigma in Families of Children With ADHD
09/19/2025
This article reviews how stigma affects families of children with ADHD—undermining help‑seeking, adherence, and well‑being—and offers clinician strategies to counter it, including destigmatizing language, brief caregiver screening, family...
This article reviews how stigma affects families of children with ADHD—undermining help‑seeking, adherence, and well‑being—and offers clinician strategies to counter it, including destigmatizing language, brief caregiver screening, family...
This article reviews how stigma...
09/19/2025
Psych Congress Network
a teenager's hand putting a bag of white pills into another teenager's hand.
Commentary
Understanding Abuse Potential Across ADHD Therapies: What Clinicians Need to Know
06/13/2025
As stimulant prescriptions for ADHD continue to rise, so does concern about their nonmedical use—particularly among adolescents and young adults.
As stimulant prescriptions for ADHD continue to rise, so does concern about their nonmedical use—particularly among adolescents and young adults.
As stimulant prescriptions for...
06/13/2025
Psych Congress Network
empty pill box on calendar with days crossed off
Commentary
Adherence and Acceptability: How Viloxazine ER Stacks Up Against Other ADHD Medications
06/13/2025
This article examines how viloxazine ER may improve adherence to ADHD treatment compared to other medications. As a non-stimulant with once-daily dosing, rapid onset, and low risk of misuse or cardiovascular issues, viloxazine ER addresses...
This article examines how viloxazine ER may improve adherence to ADHD treatment compared to other medications. As a non-stimulant with once-daily dosing, rapid onset, and low risk of misuse or cardiovascular issues, viloxazine ER addresses...
This article examines how...
06/13/2025
Psych Congress Network
A smily face button, post-it notes with A-D-H-D, and two puzzle pieces
Commentary
Combination Therapy in ADHD: When and How to Augment Treatment Safely
06/11/2025
As ADHD management becomes more nuanced, combination therapy is gaining attention as a pragmatic solution for patients who experience suboptimal outcomes or intolerable side effects on monotherapy.
As ADHD management becomes more nuanced, combination therapy is gaining attention as a pragmatic solution for patients who experience suboptimal outcomes or intolerable side effects on monotherapy.
As ADHD management becomes more...
06/11/2025
Psych Congress Network
Hand blocking small red sad face icons from large green smiling icon
Commentary
Viloxazine ER’s Impact on Comorbid Conditions: A Broader Approach to ADHD Management
06/05/2025
Managing attention-deficit/hyperactivity disorder (ADHD) often means navigating a maze of overlapping conditions—mood instability, anxiety, executive dysfunction, and more. This article explores how viloxazine ER, a non-stimulant with dual...
Managing attention-deficit/hyperactivity disorder (ADHD) often means navigating a maze of overlapping conditions—mood instability, anxiety, executive dysfunction, and more. This article explores how viloxazine ER, a non-stimulant with dual...
Managing...
06/05/2025
Psych Congress Network
Pharmacokinetics icon
Commentary
Pharmacokinetics of Viloxazine ER: What to Expect From Onset to Duration
06/05/2025
This article provides a practical breakdown of viloxazine ER’s absorption, metabolism, and elimination profiles, explaining how these features support its once-daily dosing and 24-hour symptom coverage.
This article provides a practical breakdown of viloxazine ER’s absorption, metabolism, and elimination profiles, explaining how these features support its once-daily dosing and 24-hour symptom coverage.
This article provides a...
06/05/2025
Psych Congress Network
Girl in a classroom staring off into the distance
Commentary
Beyond the Stereotype: Rethinking Sex Differences in ADHD Presentation
05/08/2026
This article explores how ADHD presents differently across sexes and why traditional diagnostic models may overlook symptoms in females.
This article explores how ADHD presents differently across sexes and why traditional diagnostic models may overlook symptoms in females.
This article explores how ADHD...
05/08/2026
Psych Congress Network
a girl playing a game on a tablet while lying on her stomach
Commentary
Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
This article reviews the role of digital therapeutics (DTx) as an adjunctive treatment modality for ADHD, highlighting FDA‑cleared products alongside investigational interventions. It summarizes clinical evidence, safety, and use...
This article reviews the role of digital therapeutics (DTx) as an adjunctive treatment modality for ADHD, highlighting FDA‑cleared products alongside investigational interventions. It summarizes clinical evidence, safety, and use...
This article reviews the role of...
04/23/2026
Psych Congress Network
Stressed mother next to crib with baby
Commentary
Postpartum Distress in Women With ADHD: Risks, Recognition, and Evidence-Based Management
09/25/2025
This article explores the challenges of postpartum distress in women with ADHD, highlighting how symptoms and psychiatric comorbidities can intensify during pregnancy and the postpartum period. It reviews current evidence, treatment...
This article explores the challenges of postpartum distress in women with ADHD, highlighting how symptoms and psychiatric comorbidities can intensify during pregnancy and the postpartum period. It reviews current evidence, treatment...
This article explores the...
09/25/2025
Psych Congress Network
Rx pad in the shape of a cell phone with pills on the screen
Commentary
Telehealth Stimulant Prescribing and Substance Misuse Risk: What the Evidence Really Says
09/23/2025
This article reviews two large studies that evaluated whether telehealth prescribing of stimulants for ADHD increases substance misuse risk.
This article reviews two large studies that evaluated whether telehealth prescribing of stimulants for ADHD increases substance misuse risk.
This article reviews two large...
09/23/2025
Psych Congress Network
Hyper child jumps on couch while mom holds head in hands
Commentary
Beyond Symptoms: The Impact of Stigma in Families of Children With ADHD
09/19/2025
This article reviews how stigma affects families of children with ADHD—undermining help‑seeking, adherence, and well‑being—and offers clinician strategies to counter it, including destigmatizing language, brief caregiver screening, family...
This article reviews how stigma affects families of children with ADHD—undermining help‑seeking, adherence, and well‑being—and offers clinician strategies to counter it, including destigmatizing language, brief caregiver screening, family...
This article reviews how stigma...
09/19/2025
Psych Congress Network
a teenager's hand putting a bag of white pills into another teenager's hand.
Commentary
Understanding Abuse Potential Across ADHD Therapies: What Clinicians Need to Know
06/13/2025
As stimulant prescriptions for ADHD continue to rise, so does concern about their nonmedical use—particularly among adolescents and young adults.
As stimulant prescriptions for ADHD continue to rise, so does concern about their nonmedical use—particularly among adolescents and young adults.
As stimulant prescriptions for...
06/13/2025
Psych Congress Network
empty pill box on calendar with days crossed off
Commentary
Adherence and Acceptability: How Viloxazine ER Stacks Up Against Other ADHD Medications
06/13/2025
This article examines how viloxazine ER may improve adherence to ADHD treatment compared to other medications. As a non-stimulant with once-daily dosing, rapid onset, and low risk of misuse or cardiovascular issues, viloxazine ER addresses...
This article examines how viloxazine ER may improve adherence to ADHD treatment compared to other medications. As a non-stimulant with once-daily dosing, rapid onset, and low risk of misuse or cardiovascular issues, viloxazine ER addresses...
This article examines how...
06/13/2025
Psych Congress Network
A smily face button, post-it notes with A-D-H-D, and two puzzle pieces
Commentary
Combination Therapy in ADHD: When and How to Augment Treatment Safely
06/11/2025
As ADHD management becomes more nuanced, combination therapy is gaining attention as a pragmatic solution for patients who experience suboptimal outcomes or intolerable side effects on monotherapy.
As ADHD management becomes more nuanced, combination therapy is gaining attention as a pragmatic solution for patients who experience suboptimal outcomes or intolerable side effects on monotherapy.
As ADHD management becomes more...
06/11/2025
Psych Congress Network
Hand blocking small red sad face icons from large green smiling icon
Commentary
Viloxazine ER’s Impact on Comorbid Conditions: A Broader Approach to ADHD Management
06/05/2025
Managing attention-deficit/hyperactivity disorder (ADHD) often means navigating a maze of overlapping conditions—mood instability, anxiety, executive dysfunction, and more. This article explores how viloxazine ER, a non-stimulant with dual...
Managing attention-deficit/hyperactivity disorder (ADHD) often means navigating a maze of overlapping conditions—mood instability, anxiety, executive dysfunction, and more. This article explores how viloxazine ER, a non-stimulant with dual...
Managing...
06/05/2025
Psych Congress Network
Pharmacokinetics icon
Commentary
Pharmacokinetics of Viloxazine ER: What to Expect From Onset to Duration
06/05/2025
This article provides a practical breakdown of viloxazine ER’s absorption, metabolism, and elimination profiles, explaining how these features support its once-daily dosing and 24-hour symptom coverage.
This article provides a practical breakdown of viloxazine ER’s absorption, metabolism, and elimination profiles, explaining how these features support its once-daily dosing and 24-hour symptom coverage.
This article provides a...
06/05/2025
Psych Congress Network

Quizzes

Viloxazine MOA Study image
Quiz
Test Your Knowledge: New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/12/2026
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that...
06/12/2026
Psych Congress Network
Weight scale and tape measure
Quiz
Test Your Knowledge: Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/12/2026
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the...
06/12/2026
Psych Congress Network
Girl in a classroom staring off into the distance
Quiz
Test Your Knowledge – Beyond the Stereotype: Rethinking Sex Differences in ADHD Presentation
05/12/2026
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation...
05/12/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
Quiz
Test Your Knowledge: The Link Between Ultra-Processed Foods and ADHD
05/12/2026
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the...
05/12/2026
Psych Congress Network
a girl playing a game on a tablet while lying on her stomach
Quiz
Test Your Knowledge—Digital Therapeutics: A Different Treatment Modality for ADHD
04/23/2026
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx for the treatment of attention-deficit/hyperactivity disorder? Test your knowledge with this short, multiple-choice quiz.
How familiar are you with DTx...
04/23/2026
Psych Congress Network
A boy's hand holding a pill that says ADHD
Quiz
Long-Term Effects of Viloxazine ER in Treatment of Pediatric ADHD
04/23/2026
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test your knowledge of viloxazine ER for the long-term treatment of pediatric ADHD.
Ready to apply the data? Test...
04/23/2026
Psych Congress Network
blocks spelling out the word "quiz"
Quiz
Screen Time, Brain Structure, and ADHD in Children
02/12/2026
Maria Mantas
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the research says? Test your knowledge with this quick quiz!
Do you remember what the...
02/12/2026
Psych Congress Network
illustration of a laptop screen displaying a test
Quiz
Stimulants and Psychosis Risk in ADHD
12/22/2025
Maria Mantas
Do you remember the findings from this systematic review?
Do you remember the findings from this systematic review?
Do you remember the findings...
12/22/2025
Psych Congress Network
A woman sleeping peacefully
Quiz
Test Your Knowledge – ADHD and Sleep: Why Non-Stimulants Might Be the Right Choice (Part 3)
10/09/2025
Sleep and ADHD intersect—see if your management playbook is up to date in 3 quick questions.
Sleep and ADHD intersect—see if your management playbook is up to date in 3 quick questions.
Sleep and ADHD intersect—see if...
10/09/2025
Psych Congress Network
Blocks that spell ADHD with pills and a stethoscope
Quiz
Test Your Knowledge – The Rise of Non-Stimulant ADHD Treatments: A Paradigm Shift?
10/08/2025
Rethink ADHD beyond stimulants—test your non-stimulant savvy with 3 quick questions.
Rethink ADHD beyond stimulants—test your non-stimulant savvy with 3 quick questions.
Rethink ADHD beyond...
10/08/2025
Psych Congress Network
Viloxazine MOA Study image
Quiz
Test Your Knowledge: New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/12/2026
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that...
06/12/2026
Psych Congress Network
Weight scale and tape measure
Quiz
Test Your Knowledge: Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/12/2026
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the...
06/12/2026
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Psilocybin Outcomes for MDD
06/11/2026
Brionna Mendoza
Test your knowledge of recent research with this quiz!
Test your knowledge of recent research with this quiz!
Test your knowledge of recent...
06/11/2026
Psych Congress Network
Desiree Matthews, PMHNP-BC
Quiz
Drug-Drug Considerations in TD Treatment
06/10/2026
Maria Mantas
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews,...
06/10/2026
Psych Congress Network
Desiree Matthews, PMHNP-BC
Quiz
Drug-Drug Considerations in TD Treatment
06/10/2026
Maria Mantas
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews,...
06/10/2026
Psych Congress Network
Girl in a classroom staring off into the distance
Quiz
Test Your Knowledge – Beyond the Stereotype: Rethinking Sex Differences in ADHD Presentation
05/12/2026
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation...
05/12/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
Quiz
Test Your Knowledge: The Link Between Ultra-Processed Foods and ADHD
05/12/2026
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the...
05/12/2026
Psych Congress Network
Nishi Bhopal, MD
Quiz
First Steps in Identifying Excessive Daytime Sleepiness
05/06/2026
Maria Mantas
What is the recommended first step to confirm whether a patient is experiencing excessive daytime sleepiness? Take this quick quiz to test your knowledge!
What is the recommended first step to confirm whether a patient is experiencing excessive daytime sleepiness? Take this quick quiz to test your knowledge!
What is the recommended first...
05/06/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Mortality Risk in Bipolar II Disorder
04/30/2026
Maria Mantas
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between...
04/30/2026
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
PGx Testing in MDD
04/27/2026
Maria Mantas
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of...
04/27/2026
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use